Top of this page
Skip navigation, go straight to the content
UCB - Aspiring to be the patient-centric biopharma leader
UCB Worldwide
Contact
Sitemap
Search
Home
Patients
Partners
Investors
Media
Job seekers
About UCB
Products
R & D
CSR
Magazine
Overview
UCB in Brief
Shares
Financials
Annual Reports
Corporate Governance
Presentations
News
Calendar
Magazine
UCB Archive
Schwarz Pharma archive
Investor News
Acquisition of own shares in the framework of employees’ long-term incentive plans
10-May-2012
First stone in UCB’s new Swiss biotechnology production unit to be set
04-May-2012
Acquisition of own shares in the framework of employees’ long-term incentive plans
03-May-2012
UCB moving ahead to become patient-centric biopharmaceutical leader
26-Apr-2012
Acquisition of own shares in the framework of employees’ long-term incentive plans
26-Apr-2012
Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
26-Apr-2012
New post-hoc analyses examined Neupro® effects on pain, depressed mood, apathy and fatigue in patients with Parkinson’s disease
26-Apr-2012
Previous
1
2
3
..
33
Next